View all news

    Complete Response Letter Issued from U.S. FDA for Investigational Long-Acting HIV Regimen

    12/21/2019
    Download(opens in new window)PDF 130 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com